North Haven, CTNCT07332442Now EnrollingIRB Ready

Sleep Apnea Clinical Trial in North Haven, CT

Access cutting-edge sleep apnea treatment through this clinical trial at a research site in North Haven. Study-provided care at no cost to qualified participants.

Sponsored by Yale University

Quick Self-Assessment

See if you qualify for this North Haven location

Preparing your pre-screening questions…

Expert Care in North Haven

Access sleep apnea specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related sleep apnea treatment provided free

Apply for This North Haven Location

Check if you qualify for this sleep apnea clinical trial in North Haven, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to North Haven

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit North Haven site if eligible
  4. 4Begin participation

About This Sleep Apnea Study in North Haven

The study design is a randomized, controlled clinical trial to test the hypothesis that arousal threshold (ArTH) will affect how individuals with obstructive sleep apnea (OSA, Apnea-Hypopnea Index (AHI) of 10/hour of higher) respond to CPAP therapy regarding adherence and cognitive function (executive function). Investigators hypothesize that raising ArTH with eszopiclone will improve adherence to CPAP and neurocognitive function with CPAP therapy. Investigators also hypothesize that a lower baseline ArTH is associated with worse CPAP adherence, while a higher baseline ArTH is associated with improved neurocognitive outcomes with CPAP therapy.

Sponsor: Yale University

Who Can Participate

Inclusion Criteria

Able to provide informed consent.
Clinically confirmed new diagnosis of OSA:
Polysomnography AHI ≥ 10 per hour of sleep and/or
Home sleep apnea testing, respiratory even index, REI ≥ 10 per hour of recording

Exclusion Criteria

Known non-OSA related conditions associated with sleep-disordered breathing (e.g., a central disorder of hypersomnolence, neurological, neuromuscular, or pulmonary disorder)
Use of sleep-inducing medications (e.g., other non-benzodiazepine sedative hypnotic-drugs \[e.g., zoldpidem\], benzodiazepines, non-selective antihistamines, trazodone, opiates, barbituates)
Known hypersensitivity reaction to eszopiclone
Contraindications to its use based on medical history or function (e.g., dizziness at baseline or established mobility problems or imbalance)
History of complex sleep behaviors (e.g., NREM or REM parasomnias)
Concomitant use of ≥ 2 servings of alcohol per night or other CNS depressant for 2 weeks prior or throughout the study
Sleep opportunity of less than 7 hours
Severe active depression or other mental health disorders (e.g., schizophrenia, bipolar disorder, personality disorder).
History of sleep-walking, sleep-driving, and engaging in other activities while not fully awake
History of motor vehicle accidents related to sleepiness and/or motor vehicle "near misses" (e.g. sleepiness during driving or lane changes)
Severe hepatic impairment (liver function tests 2 X the upper limit of normal)
Unstable medical condition (e.g., decompensated heart failure, end-stage chronic obstructive pulmonary disease, end-stage renal disease)
Females of childbearing potential who are pregnant, breastfeeding, or intend to become pregnant, and women who are in the process of egg donation .

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in North Haven?

Yes, this clinical trial (NCT07332442) has an active research site in North Haven, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sleep Apnea Treatment Options in North Haven, CT

If you're searching for sleep apnea treatment options in North Haven, CT, this clinical trial (NCT07332442) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our North Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sleep apnea specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sleep apnea clinical trials near you to find additional studies recruiting in your area.

More Lupus Trials in North Haven, CT

See all lupus clinical trials recruiting in North Haven — not just this study.

Browse Lupus Trials in North Haven →

Browse More Trials by Condition

Lupus TrialsSleep Apnea TrialsPrurigo Nodularis TrialsSystemic Lupus Erythematosus TrialsAll Conditions →

Ready to Join in North Haven?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · North Haven, CT